ArticleJournal of cancer research and clinical oncology2019

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.

Francesco Marampon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.